<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pancreatic cancer supportive care &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pancreatic-cancer-supportive-care/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 18 Oct 2025 11:16:08 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>pancreatic cancer supportive care &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>AI-Enhanced Multimodal Care for Pancreatic Cancer</title>
		<link>https://bioengineer.org/ai-enhanced-multimodal-care-for-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 18 Oct 2025 11:16:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[AI-enhanced multimodal oncology]]></category>
		<category><![CDATA[digital health in chemotherapy]]></category>
		<category><![CDATA[European multicenter cancer trials]]></category>
		<category><![CDATA[pancreatic cancer supportive care]]></category>
		<category><![CDATA[patient-centered AI interventions]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ai-enhanced-multimodal-care-for-pancreatic-cancer/</guid>

					<description><![CDATA[In a groundbreaking European initiative poised to redefine supportive care in oncology, the RELEVIUM project launches a multicenter randomized controlled trial focused on the integration of digital technology and artificial intelligence (AI) to enhance the quality of life for patients battling advanced pancreatic cancer. This ambitious study, spanning cancer centers in Estonia, Israel, and Germany, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">283275</post-id>	</item>
	</channel>
</rss>
